USPTO serial 97557151
NORMGENE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- MEYERS, MORGAN LAURA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NORMGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Charlottesville, VA
Charlottesville, VA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick C. Asplin
PATRICK C. ASPLIN FLORA PETTIT530 EAST MAIN STREETCHARLOTTESVILLE, VA 22902UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical diagnostic test strips, patches, reagents and assays to analyze gene expression profiles in blood samples to assess whether an individual is healthy or at risk of contracting or suffering from an autoimmune disease, cardiovascular disease, an inflammatory disease, a neurological disease, an infectious disease, an oncological disease or other health condition which may adversely impact such individual's health | ACTIVE | — |
| 044 | Medical testing services, namely, analyzing gene expression profiles in blood samples to assess whether an individual is healthy or at risk of contracting or suffering from an autoimmune disease, cardiovascular disease, an inflammatory disease, a neurological disease, an infectious disease, an oncological disease or other health condition which may adversely impact such individual's health; Medical information services, namely, providing medical information based on an individual's gene expression profile as to whether such individual is healthy or at risk of contracting or suffering from an autoimmune disease, cardiovascular disease, an inflammatory disease, a neurological disease, an infectious disease, an oncological disease or other health condition which may adversely impact such individual's health | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 15, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 15, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 12, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 18, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 18, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 28, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 12, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 9, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 24, 2022 | NWAP | NEW APPLICATION ENTERED | — |